Eyepoint Pharmaceuticals (EYPT) Stock Price
$6.24 1.6%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Eyepoint Pharmaceuticals, AI stock picks, stock alerts and much more.
EYPT AI Stock Analysis
AI stock analysis for EYPT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Eyepoint Pharmaceuticals (EYPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Eyepoint Pharmaceuticals (EYPT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Eyepoint Pharmaceuticals (EYPT), currently trading at $6.24, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About EYPT
-
EyePoint Pharmaceuticals, Inc.
-
Symbol
EYPT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
428.9M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$25.72 0.1% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.81 3.7% |
2 |
 |
Moderna MRNA |
$33.85 0.9% |
3 |
 |
Anavex Life Sciences AVXL |
$9.56 0.5% |
5 |
 |
BridgeBio Pharma BBIO |
$36.74 1.3% |
5 |
News
EYPT Alternative Data
Web Traffic
Eyepoint Pharmaceuticals receives an estimated 4534 monthly visitors to eyepointpharma.com.
-
Web Traffic
4534
-
Change from Previous Month
29.1%
-
3 Month Change
27.3%
-
YoY Change
27.3%
News Mentions
Eyepoint Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Eyepoint Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Eyepoint Pharmaceuticals has 1,417 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
1417
-
Daily Change
0.1%
-
1 Month Change
0.3%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Facebook Engagement
Eyepoint Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Followers
14,443 are following Eyepoint Pharmaceuticals on LinkedIn, up by 1.9% over the last month.
-
LinkedIn Followers
14443
-
Daily Change
0.1%
-
1 Month Change
1.9%
-
3 Month Change
7.2%
Job Postings
Eyepoint Pharmaceuticals currenly has an estimated 8 open job postings, up by 14.3% over the last month.
-
Job Postings
8
-
Daily Change
0%
-
1 Month Change
14.3%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Eyepoint Pharmaceuticals has 196 employees, up by 1% over the last month.
-
LinkedIn Employees
196
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
3.2%
-
YoY Change
3.2%
Business Outlook
According to employee reviews, the business outlook among employees at Eyepoint Pharmaceuticals is 44 out of 100 (neutral).
-
Business Outlook
44
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
EYPT Financials
EYPT Key Metrics
-
Total Revenue
$10.5M
-
Net Income
-$29.4M
-
Earnings per Share
-$0.54
-
Free cash flow
-$40.6M
-
EBITDA
-$29M
-
EBITDA Ratio
-2.75114
-
Total Assets
$300.9M
EYPT 2-year Revenue & Income
EYPT 2-year Free Cash Flow
EYPT Technicals
EYPT SMA
EYPT RSI
FAQ
What's the current price of Eyepoint Pharmaceuticals (EYPT) Stock?
The price of an Eyepoint Pharmaceuticals (EYPT) share is $6.24.
What's the market cap of Eyepoint Pharmaceuticals?
The current market cap of Eyepoint Pharmaceuticals is 428.9M.
Should I buy or sell EYPT?
Eyepoint Pharmaceuticals exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Eyepoint Pharmaceuticals a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Eyepoint Pharmaceuticals stock. There are several bearish signals and market challenges that could negatively impact Eyepoint Pharmaceuticals' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Eyepoint Pharmaceuticals (EYPT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Eyepoint Pharmaceuticals stock right now, as the outlook appears bearish.
What are some stocks similar to Eyepoint Pharmaceuticals (EYPT) that investors often compare it to?
Eyepoint Pharmaceuticals (EYPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Eyepoint Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Eyepoint Pharmaceuticals' stock price to be around $5.8 in 2026. Starting from the current price of $6.24, this represents a 7% change in price, indicating a bearish outlook for the stock.
How to buy Eyepoint Pharmaceuticals (EYPT) Stock?
Eyepoint Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Eyepoint Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.